273 related articles for article (PubMed ID: 24927278)
1. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous quantification of Camptosar and its metabolite SN-38 in mouse plasma and tissues.
Bardin S; Guo W; Johnson JL; Khan S; Ahmad A; Duggan JX; Ayoub J; Ahmad I
J Chromatogr A; 2005 May; 1073(1-2):249-55. PubMed ID: 15909526
[TBL] [Abstract][Full Text] [Related]
3. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
[TBL] [Abstract][Full Text] [Related]
4. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
Rivory LP; Robert J
J Chromatogr B Biomed Appl; 1994 Nov; 661(1):133-41. PubMed ID: 7866541
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
Owens TS; Dodds H; Fricke K; Hanna SK; Crews KR
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):65-74. PubMed ID: 12668072
[TBL] [Abstract][Full Text] [Related]
6. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
de Bruijn P; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):277-85. PubMed ID: 9367218
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of Irinotecan and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometric.
Zhang W; Dutschman GE; Li X; Ye M; Cheng YC
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3038-44. PubMed ID: 19648066
[TBL] [Abstract][Full Text] [Related]
9. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
[TBL] [Abstract][Full Text] [Related]
10. Fast liquid chromatography-tandem mass spectrometry method for routine assessment of irinotecan metabolic phenotype.
Corona G; Elia C; Casetta B; Toffoli G
Ther Drug Monit; 2010 Oct; 32(5):638-46. PubMed ID: 20683392
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat.
Yang X; Hu Z; Chan SY; Goh BC; Duan W; Chan E; Zhou S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):221-8. PubMed ID: 15936253
[TBL] [Abstract][Full Text] [Related]
12. Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.
Ragot S; Marquet P; Lachâtre F; Rousseau A; Lacassie E; Gaulier JM; Dupuy JL; Lachâtre G
J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):175-84. PubMed ID: 10676997
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
Marangon E; Posocco B; Mazzega E; Toffoli G
PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of the lactone and carboxylate forms of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in rat plasma by high performance liquid chromatography.
Kaneda N; Hosokawa Y; Yokokura T
Biol Pharm Bull; 1997 Jul; 20(7):815-9. PubMed ID: 9255427
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
Schoemaker NE; Rosing H; Jansen S; Schellens JH; Beijnen JH
Ther Drug Monit; 2003 Feb; 25(1):120-4. PubMed ID: 12548157
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.
Basu S; Zeng M; Yin T; Gao S; Hu M
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():34-41. PubMed ID: 26894853
[TBL] [Abstract][Full Text] [Related]
17. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection.
Zhuang Q; Liu X; Sun Z; Wang H; Jiang J
J Pharm Biomed Anal; 2019 Jun; 170():112-123. PubMed ID: 30921645
[TBL] [Abstract][Full Text] [Related]
18. Determination by liquid chromatography with fluorescence detection of total 7-ethyl-10-hydroxy-camptothecin (SN-38) in beagle dog plasma after intravenous administration of liposome-based SN-38 (LE-SN38).
Guo W; Ahmad A; Khan S; Dahhani F; Wang YF; Ahmad I
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):85-92. PubMed ID: 12798168
[TBL] [Abstract][Full Text] [Related]
19. A sensitive and rapid liquid chromatography tandem mass spectrometry method for quantitative determination of 7-ethyl-10-hydroxycamptothecin (SN-38) in human plasma containing liposome-based SN-38 (LE-SN38).
Khan S; Ahmad A; Ahmad I
Biomed Chromatogr; 2003 Dec; 17(8):493-9. PubMed ID: 14648604
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma.
Sumiyoshi H; Fujiwara Y; Ohune T; Yamaoka N; Tamura K; Yamakido M
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):309-16. PubMed ID: 8548021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
